Structure
atLeast majority ProS Experiment
:order disorder conflict PDB cluster ProS Pfam Domain SEG
331
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Seq 253-308 Hetero trimer : IID00436 Complex ,
IID00470 Complex
Region 1s9k E 257-308 order
Region 1a02 J 253-256 disorder
Region 1a02 J 257-308 order
Seq 254-314 Hetero tetramer : IID00441 Complex
Region 1t2k C 254-314 order
Seq 254-315 Hetero dimer : IID00436 Complex
Region 1fos H 254-255 disorder
Region 1fos H 256-313 order
Region 1fos H 314-315 disorder
Region 1fos F 254-256 disorder
Region 1fos F 257-313 order
Region 1fos F 314-315 disorder
Region 5t01 B 254-313 order
Region 5t01 B 314-315 disorder
Region 5t01 A 254-313 order
Region 5t01 A 314-315 disorder
Region 1jnm B 254-310 order
Region 1jnm B 311-315 disorder
Region 1jnm A 254-309 order
Region 1jnm A 310-315 disorder
Region 1jun B 276-314 order
Region 1jun B 314-314 high_rmsd
Region 1jun A 276-314 order
Region 1jun A 314-314 high_rmsd
Seq 277-308 Hetero tetramer :
Region 5fv8 D 277-306 order
Region 5fv8 D 307-308 disorder
Region 5fv8 E 277-308 order
249-249 Phosphoserine; by GSK3-beta
243-243 Phosphoserine; by DYRK2 and GSK3-beta
239-239 Phosphothreonine; by GSK3-beta
93-93 Phosphothreonine; by PAK2
89-89 Phosphothreonine; by PAK2
73-73 Phosphoserine; by MAPK8 and PLK3
63-63 Phosphoserine; by MAPK8 and PLK3
8-8 Phosphothreonine; by PAK2
2-2 Phosphothreonine; by PAK2
286-286 Phosphothreonine; by PAK2
56-56 N6-acetyllysine; alternate
Prediction
ProS 1-13,24-44,58-63,74-79,106-148,171-177,196-198,231-237,248-249,328-331
Disorder 1-73,75-77,79-79,82-103,107-108,125-245,322-331
Order 74-74,78-78,80-81,104-106,109-124,246-321
SEG 139-162
,178-196
,198-220
Function
Function in SwissProt
Transcription factor that recognizes and binds to the enhancer heptamer motif 5'-TGA[CG]TCA-3' (PubMed:10995748, PubMed:22083952). Promotes activity of NR5A1 when phosphorylated by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation (PubMed:17210646). Involved in activated KRAS-mediated transcriptional activation of USP28 in colorectal cancer (CRC) cells (PubMed:24623306). Binds to the USP28 promoter in colorectal cancer (CRC) cells (PubMed:24623306).
Biological Process
See also
Diagram with PDB data
NFATC2/FOS/JUN/DNA STRUCTURE OF THE DNA BINDING DOMAINS OF NFAT, FOS AND JUN BOUND TO DNA